Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LEGN

Recent news which mentions LEGN

< Previous 1 2 3 4 Next >
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
Tickers JNJ LEGN NEWS NVS
Tags Expert Ideas FDA Biotech
From Benzinga
Unveiling 9 Analyst Insights On Legend Biotech
Tickers LEGN
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
Tickers ASIA BMY JNJ LEGN
Tags Markets Asia Market News
From Benzinga
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Tickers BMY JNJ LEGN NEWS
Tags General why it's moving Benzinga
From Benzinga
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
Tickers BMY JNJ LEGN NEWS
Tags General Benzinga Stories That Matter
From Benzinga
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Tickers BGNE CLOV HCM LEGN
Tags Pre/Market Outlook Small Cap LEGN
From Benzinga
Earnings Scheduled For March 11, 2024
Tickers ALTO ASAN ASRT AVO
Tags FTRE OSG NNBR
From Benzinga
Earnings Preview: Legend Biotech
Tickers LEGN
Tags Earnings Market News BZI/EP
From Benzinga
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
Tickers ACLX BMY GILD JNJ
Tags Expert Ideas Initiation Biotech
From Benzinga
What 4 Analyst Ratings Have To Say About Legend Biotech
Tickers LEGN
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
Tickers AZN BMY GILD GRCL
Tags GILD Health Care News
From Benzinga
As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?
Tickers ASIA BABA BGNE CHIR
Tags Specialty ETFs General Benzinga
From Benzinga
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
Tickers ACLX JNJ LEGN NEWS
Tags Reiteration Price Target Expert Ideas
From Benzinga
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
Tickers ALNY ARWR IBB LEGN
Tags Sector ETFs IBB Expert Ideas
From Benzinga
Key Takeaways From Legend Biotech Analyst Ratings
Tickers LEGN
Tags LEGN Benzinga Analyst Ratings
From Benzinga
Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say
Tickers ACLX JNJ LEGN
Tags JNJ LEGN Briefs
From Benzinga
Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment
Tickers BMY JNJ LEGN SPX
Tags TSVT SPX BMY
From MarketWatch
Earnings Scheduled For November 20, 2023
Tickers A BLRX BRBR CENT
Tags FIHL UPXI Market News
From Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
Tickers CVRX JNJ LEGN NVS
Tags Market News PTGX Recent Press Releases
From Motley Fool
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug
Tickers JNJ LEGN
Tags Analyst Color Health Care News
From Benzinga
Analyst Ratings for Legend Biotech
Tickers LEGN
Tags Benzinga LEGN BZI/AAR
From Benzinga
The Latest Analyst Ratings for Legend Biotech
Tickers LEGN
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
3 Biotech Stocks That Analysts Are Drooling Over
Tickers CRSP LEGN ROIV
Tags Market News CRSP LEGN
From InvestorPlace
The Latest Analyst Ratings for Legend Biotech
Tickers LEGN
Tags Benzinga LEGN BZI/AAR
From Benzinga
The Latest Analyst Ratings for Legend Biotech
Tickers LEGN
Tags LEGN Benzinga Analyst Ratings
From Benzinga
Legend Biotech's Breakthrough in Multiple Myeloma Study Prompts Positive Analyst Forecast
Tickers LEGN
Tags News Trading Ideas Health Care
From Benzinga
Expert Ratings for Legend Biotech
Tickers LEGN
Tags LEGN Benzinga Analyst Ratings
From Benzinga
Analyst's Verdict on Legend Biotech: Doubts On Commercial Execution, Long- Term Market Share
Tickers LEGN
Tags Briefs LEGN Biotech
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
Tickers ANNX APPS BNGO CAL
Tags F LDOS TEVA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Tickers AAPL ANAB AVNS AZUL
Tags AZUL NSC CNI
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.